Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics. The lead drug is a formulation of doxorubicin, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback